Delivery Order SPE2DB22D3501-SPE2DB24FUP65
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,009.19 Firm Fixed Price Delivery Order contract covers the provision of MICROGESTIN FE 1.5-30 TAB 28S, a type of prescription medication, with a period of performance through February 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,346.28, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 10, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award, with ID SPE2DX15D3005|SPE2DX24F3MTS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, with a ceiling value of $4,245.19 and a completion date of November 7, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,887.44 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The award is not associated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical. This IDC serves as the primary vehicle...
- This federal contract award is for the delivery of pharmaceutical products, including the medication Microgestin FE 1-20 Tablet 28s, to the Defense Logistics Agency (DLA). The $1,231.99 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies medical products to various federal...
- This federal contract award, valued at $1,139.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of March 5, 2025. The contract covers the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, valued at $1,489.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554834923 - MICROGESTIN FE 1-20 TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...
- This federal contract award, valued at $1,753.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, with a completion date of September 22, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at...
- Amerisourcebergen Drug Corp has received a $2,013.72 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply MICROGESTIN FE 1-20 TABLET 28S. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility with completion by December 11, 2023. No set-aside designation was applied. As a prime contractor and leading pharmaceutical distributor, Amerisourcebergen Drug Corp routinely supports DLA Troop Support Medical by providing...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,942.59 Firm Fixed Price delivery order contract is for the provision of medical supplies, including pharmaceuticals such as low-ogestrel-28 tablets. The contract has an ultimate completion date of September 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUP65Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,674.45 firm-fixed-price delivery order is for the pharmaceutical product MICROGESTIN FE 1.5-30 TAB 28S. There was no set-aside used for this award. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This delivery order award is made under that larger IDC contracting vehicle.